Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2007
12/27/2007CA2655962A1 Crystalline duloxetine hydrochloride
12/27/2007CA2655933A1 Polynucleotides and polypeptide sequences involved in cancer
12/27/2007CA2655904A1 Prodrugs of 5-amino-3-(3'-deoxy-.beta.-d-ribofuranosyl)-thiazolo[4,5-d]pyrimidin-2,7-dione
12/27/2007CA2655895A1 Agent for overcoming resistance to anti-cancer agent
12/27/2007CA2655801A1 Therapeutic or prophylactic agent for leukemia
12/27/2007CA2655789A1 Enantiomerically pure flavone derivatives for the treatment of poliferative disorders and processes for their preparation
12/27/2007CA2655788A1 Skin external preparation containing triterpenic acid
12/27/2007CA2655780A1 3-aminoimidazo [1,2-a] pyridine derivatives as sglt inhibitors
12/27/2007CA2655759A1 Compositions and kits comprising a melatonin component and a chondroprotective component
12/27/2007CA2655753A1 Tricyclic compound and pharmaceutical use thereof
12/27/2007CA2655744A1 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof
12/27/2007CA2655728A1 Phenylpentadienoyl derivatives and their use as par 1 antagonists
12/27/2007CA2655724A1 Combinations comprising staurosprorines
12/27/2007CA2655654A1 New carbonylated (aza)cyclohexanes as dopamine d3 receptor ligands
12/27/2007CA2655643A1 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof
12/27/2007CA2655604A1 Cyclopropyl amine derivatives
12/27/2007CA2655598A1 Substituted 8-[6-amino-3-pyridyl]xanthines
12/27/2007CA2655574A1 Imidazole kv1.5 potassium channel inhibitors
12/27/2007CA2655573A1 Therapeutic or prophylactic agent for multiple sclerosis
12/27/2007CA2655570A1 Dha esters and use thereof in treatment and prevention of cardiovascular disease
12/27/2007CA2655561A1 Pyrazoloquinazolinones as parp inhibitors
12/27/2007CA2655527A1 Cinnamoyl-piperazine derivatives and their use as par-1 antagonists
12/27/2007CA2655524A1 Arylsulfonamidyl tetralin derivatives and uses thereof
12/27/2007CA2655491A1 Prolyl hydroxylase inhibitors
12/27/2007CA2655468A1 Il-8 receptor antagonist
12/27/2007CA2655403A1 Antibacterial benzothiazoles and thiazolopyridines
12/27/2007CA2655399A1 Pyrrolidine derivatives having activity at the glyt1 transporter
12/27/2007CA2655296A1 Methods of using a thiazole derivative
12/27/2007CA2655138A1 Compositions comprising chitin microparticles and their medical uses
12/27/2007CA2655084A1 Novel heteroaryl substituted benzoxazoles
12/27/2007CA2655059A1 Hexahydro-isoalpha acid based protein kinase modulation cancer treatment
12/27/2007CA2655047A1 Beta acid based protein kinase modulation cancer treatment
12/27/2007CA2655016A1 Use of adenosine a1 antagonists in radiocontrast media induced nephrophaty
12/27/2007CA2655014A1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors
12/27/2007CA2654872A1 Galenical formulations of aliskiren and hydrochlorothiazide
12/27/2007CA2654822A1 Arylsulfonyl naphthalene derivatives and uses thereof
12/27/2007CA2654781A1 2-pyrazinecarboxamide derivatives
12/27/2007CA2654493A1 Tablets comprising candesartan cilexetil
12/27/2007CA2654464A1 Compositions and kits comprising a melatonin component and a flavanol component
12/27/2007CA2654459A1 Compositions and kits comprising a melatonin component and an omega-3-fatty acid component
12/27/2007CA2654354A1 Amino derivatives of b-homoandrostanes and b-heteroandrostanes
12/27/2007CA2654262A1 Kv1.5 potassium channel inhibitors
12/27/2007CA2654243A1 Oral pharmaceutical composition of a poorly water-soluble active substance
12/27/2007CA2654237A1 Quinoline derivatives, their preparation, their use, and medicaments comprising them
12/27/2007CA2654234A1 Cyanoquinoline derivatives, their preparation, their use, and medicaments comprising them
12/27/2007CA2654115A1 Aqueous suspensions of tmc278
12/27/2007CA2654113A1 Sustained release formulations of aromatase inhibitors
12/27/2007CA2653758A1 Tetralin and indane derivatives and uses thereof
12/27/2007CA2653355A1 Substituted phenyl methanone derivatives
12/27/2007CA2653233A1 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
12/27/2007CA2653012A1 Process for the production of 2-[4-(3- and 2-fluorobenzyloxy) benzylamino) propan amides
12/27/2007CA2652859A1 Pyrazinones as cellular proliferation inhibitors
12/27/2007CA2652633A1 Crystalline forms of gemcitabine amide prodrug, compositions and use thereof
12/27/2007CA2652612A1 Inhibitors of akt (protein kinase b)
12/27/2007CA2649648A1 Adenosine a3 receptor agonists
12/27/2007CA2637036A1 Water stabilized aerosol formulation system and method of making
12/27/2007CA2635314A1 Steroid-containing sustained release intraocular implants and related methods
12/26/2007EP1870468A2 LPS with reduced toxicity from genetically modified gram negative bacteria
12/26/2007EP1870416A1 Sulphonamido-macrocycles as tie2 inhibitors
12/26/2007EP1870414A1 Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-met autophosphorylation inhibiting potency
12/26/2007EP1870413A1 Antipruritic agent for pruritus caused by multiple sclerosis
12/26/2007EP1870412A1 2-thioethenyl carbapenem derivative
12/26/2007EP1870411A1 Process for the preparation and purification of valgancyclovir
12/26/2007EP1870410A1 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
12/26/2007EP1870409A1 Benzimidazole compound
12/26/2007EP1870405A1 Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands
12/26/2007EP1870404A1 Agent for treatment of hematopoietic tumor
12/26/2007EP1870402A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
12/26/2007EP1870401A1 1,4-substituted piperazine derivative
12/26/2007EP1870400A1 Salts and crystalline salt forms of an 2-indolinone derivative
12/26/2007EP1870399A1 Hydroxamate derivatives useful as deacetylase inhibitors
12/26/2007EP1870122A2 Metered dose inhaler
12/26/2007EP1870110A1 Preparation comprising microparticles of complex composed of nucleic acid molecule and collagen
12/26/2007EP1870105A1 Use of fucans in the treatment of psoriasis
12/26/2007EP1870104A1 Composition for the relief of joint pain
12/26/2007EP1870103A2 Use of uridine in combination with choline for the treatment of memory disorders
12/26/2007EP1870102A1 Solid forms containing meloxicam with improved taste and process for their preparation
12/26/2007EP1870101A1 Aerosol formulation for inhalation containing an anticholinergic agent
12/26/2007EP1870100A1 Pharmaceutical composition for oral application comprising ethyl 3-(2-(4-(hexyloxycarbonylamidino)phenylaminomethyl)-1-methyl-1H-benzimidazole-5-carbonyl)-2-pyridylamino)propionate mesylate
12/26/2007EP1870099A1 Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
12/26/2007EP1870098A2 Combined use of valsartan and calcium channel blockers for therapeutic purposes
12/26/2007EP1870097A1 Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
12/26/2007EP1870096A2 Compositions for affecting weight loss
12/26/2007EP1870095A1 Composition for increasing anti-oxidation activity in blood
12/26/2007EP1870093A1 Pharmaceutical combination comprising adenosine A1 receptor antagonists and radiocontrast media
12/26/2007EP1870092A2 Ocular implant made by a double extrusion process
12/26/2007EP1870089A1 A gynecological pharmaceutics-containing microspherical vascular suppository of sodium alginate and its preparation method
12/26/2007EP1870049A2 Spine distraction implant
12/26/2007EP1869185A1 Conjugate comprising p21 protein for the treatment of cancer
12/26/2007EP1869060A1 Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof
12/26/2007EP1869056A1 Novel 5-substituted 7-amino-ý1,3¨thiazoloý4,5-d¨pyrimidine derivatives
12/26/2007EP1869055A1 Novel 5,7-disubstituted ý1,3¨thiazoloý4,5-d¨pyrimidin-2(3h)-one derivatives
12/26/2007EP1869054A2 Condensed isoxaline derivatives as inhibitors of phosphodiesterase type-iv
12/26/2007EP1869053A1 Substituted 4,5,6,7-tetrahydro-isoxazolo[4,5-c]pyridine compounds and their use in the production of medicaments
12/26/2007EP1869052A1 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
12/26/2007EP1869051A1 4-piperazinylthieno ý2,3-d¨pyrimidine compounds as platelet aggregation inhibitors
12/26/2007EP1869050A1 Novel substituted diazabicyclo derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
12/26/2007EP1869049A1 Imidazopyridazine compounds
12/26/2007EP1869047A1 Purine derivatives as receptor-tyrosine kinase activityinhibitors
12/26/2007EP1869046A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases
1 ... 3444 3445 3446 3447 3448 3449 3450 3451 3452 3453 3454 3455 3456 3457 3458 3459 3460 3461 3462 3463 3464 ... 7860